Reference Method and Reference Material Are Necessary Tools to Reveal the Variability of Cystatin C Assays

Archives of Pathology and Laboratory Medicine

Volumn 140, Issue 2, 2016, Pages 117-118

  Bargnoux, Anne Sophie ^a   Kuster, Nils ^a   Delatour, Vincent ^b   Delanaye, Pierre ^c   González Antuña, Ana ^c,d   Cristol, Jean Paul ^a   Piéroni, Laurence ^e   Cavalier, Etienne ^c  

^a UNIV MONTPELLIER   (France)

^b LABORATOIRE NATIONAL DE MÉTROLOGIE ET D ESSAIS LNE   (France)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d UNIVERSITY OF OVIEDO   (Spain)

^e CENTRE HOSPITALIER D AVIGNON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATIN C;

BLOOD; BLOOD ANALYSIS; HUMAN; PATHOLOGY; PROCEDURES; REFERENCE VALUE; STANDARD; STANDARDS;

BLOOD CHEMICAL ANALYSIS; CYSTATIN C; HUMANS; PATHOLOGY, CLINICAL; REFERENCE STANDARDS; REFERENCE VALUES;

EID: 84957932689     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2015-0198-LE     Document Type: Letter

References (5)

1. Eckfeldt JH, Karger AB, Miller WG, Rynders GP, Inker LA. Performance in measurement of serum cystatin C by laboratories participating in the College of American Pathologists 2014 CYS survey. Arch Pathol Lab Med. 2015;139(7):888-893. doi: 10.5858/arpa.2014-0427-CP.
2. Piéroni L, Delanaye P, Boutten A, et al; Société Française De Biologie Clinique (SFBC). A multicentric evaluation of IDMS-traceable creatinine enzymatic assays. Clin Chim Acta. 2011;412(23-24): 2070-2075.
3. Grubb A, Blirup-Jensen S, Lindstr öm V, Schmidt C, Althaus H, Zegers I; IFCC Working Group on Standardisation of Cystatin C (WG-SCC). First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clin Chem Lab Med. 2010;48(11):1619-1621.
4. González-Antun?a A, Rodŕ?guez-González P, Ohlendorf R, Henrion A, Delatour V, Garć?a Alonso JI. Determination of Cystatin C in human serum by isotope dilution mass spectrometry using mass overlapping peptides. J Proteomics. 2015;112:141-155.
5. Shlipak MG, Matsushita K, Ä rnlöv J, et al; CKD Prognosis Consortium. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med. 2013;369(10):932-943.